Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Clinical trial NCT01556815 · UNKNOWN

Trial details

NCT number: NCT01556815
Sponsor: Shandong Cancer Hospital and Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

PHENYTOIN/SORAFENIB [VA Drug Interaction]Liver Neoplasms Carcinoma, Hepatocellular Digestive System Neoplasms Neoplasms by Site Liver Diseases Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction]HBV

Start date: 2012-05-01
Primary completion: 2014-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.